Winamp Logo
Listen to The Lancet Oncology Cover
Listen to The Lancet Oncology Profile

Listen to The Lancet Oncology

English, Sciences, 1 seasons, 193 episodes, 1 day 13 hours 29 minutes
About
The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
Episode Artwork

In conversation with... Georgios Lyratzopoulos

Dr Georgios Lyratzopoulos (University College London, London, UK) discusses his two papers from the International Cancer Benchmarking Partnership on the use of chemotherapy or radiotherapy in eight common cancers in Norway, the UK, Canada, and Australia.
27/02/202434 minutes 43 seconds
Episode Artwork

In conversation with... Shankar Shiva

Senior Editor Owen Stretton talks to Professor Shankar Shiva from the Peter MacCallum Cancer Centre in Melbourne about the International Society of Stereotactic Radiosurgery’s new systematic review and practice guidelines for stereotactic body radiotherapy in primary renal cell carcinoma.
02/01/202413 minutes 53 seconds
Episode Artwork

In conversation with... Neerja Bhatla

Professor Neerja Bhatla (All India Institute of Medical Sciences, New Delhi, India) discusses her Article on the Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India.
28/11/202312 minutes 24 seconds
Episode Artwork

In conversation with... Chandra Are

Dr Chandra Are (University of Nebraska Medical Center, Omaha, NE, USA) discusses highlights and recommendations from the Lancet Oncology Commission on Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide.
01/11/202343 minutes 49 seconds
Episode Artwork

In conversation with... Ticiana Leal

Ticiana Leal (Winship Cancer Institute at Emory University, Atlanta, GA, USA) discusses her paper on Tumour Treating Fields.
30/08/20239 minutes 1 second
Episode Artwork

In conversation with... Xuesong Han

Xuesong Han (American Cancer Society, Atlanta, GA, USA) discusses her study on changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA.
12 minutes 31 seconds
Episode Artwork

In conversation with... Carlos Fernández de Larrea and Damian Green

Carlos Fernández de Larrea (Hospital Clínic de Barcelona, Barcelona, Spain) and Damian Green (Fred Hutch Cancer Center, Seattle, WA, USA) discuss their studies on BCMA CAR T cells in patients with relapsed or refractory multiple myeloma.
03/07/202333 minutes 50 seconds
Episode Artwork

In conversation with... Madeline Pe

Madeline Pe (EORTC, Brussels, Belgium) discusses her Policy Review on the innovative medicines initiative, an expansion of the Setting International Standards in Analysing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials (SISAQOL) initiative.
01/06/202314 minutes 1 second
Episode Artwork

In conversation with... Kadia Petricca and Joyce Kambugu

Dr Kadia Petricca (SickKids Hospital, Toronto, Canada), Dr Joyce Kambugu (Uganda Cancer Institute, Kampala, Uganda), and Dr Avi Denburg (SickKids Hospital) discuss their paper “Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa”.
03/05/202328 minutes 40 seconds
Episode Artwork

In Conversation With... Mark Lythgoe

Dr Mark Lythgoe (Imperial College London, London, UK), discusses his new Review, "From The European Medicines Agency to Project Orbis: New activities and challenges to facilitate UK Oncology Drug Approval following Brexit".
28/03/202314 minutes 11 seconds
Episode Artwork

In conversation with... Janet Brown

Prof Janet Brown (University of Sheffield, Sheffield, UK) discusses the phase 2/3 STAR trial on treatment cessation versus continuation with tyrosine kinase inhibitors in advanced renal cell carcinoma.
01/03/202320 minutes 43 seconds
Episode Artwork

In conversation with... Valerie Speirs

Prof Valerie Speirs (University of Aberdeen, Aberdeen, Scotland) discusses her Systematic Review on genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers in male breast cancer.
30/01/202317 minutes 40 seconds
Episode Artwork

In conversation with... Sameer Bakhshi

Prof Sameer Bakhshi, (All India Institute of Medical Sciences, New Delhi, India) discusses his Article on sex disparities in childhood cancer in India.
04/01/202323 minutes 2 seconds
Episode Artwork

In conversation with... Shankar Siva

Shankar Siva (Peter MacCallum Cancer Centre, Melbourne, Australia) discusses his Article on 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma.
28/11/20228 minutes 30 seconds
Episode Artwork

In conversation with... Mark Lawler and Richard Sullivan

Mark Lawler (Queen’s University Belfast, Belfast, UK) and Richard Sullivan (Kings College London, London, UK) discuss the European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission.
15/11/202223 minutes 20 seconds
Episode Artwork

In conversation with... Samar Alhomoud

Samar Alhomoud (King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia) discusses her review on progress and remaining challenges for cancer control in the Gulf Cooperation Council.
01/11/202210 minutes 33 seconds
Episode Artwork

In conversation with... Inge Marie Svane

Inge Marie Svane (Copenhagen University Hospital, Copenhagen, Denmark) discusses her Review on clinical advances and ongoing trials on mRNA vaccines for cancer treatment.
26/09/20228 minutes 11 seconds
Episode Artwork

In conversation with... Eline Giraud and Elise Smolders

Eline Giraud and Elise Smolders from the (Radboud University Medical Center, Nijmegen, Netherlands) discuss their Review on QT interval prolongation potential of anticancer and supportive drugs.
31/08/202211 minutes 39 seconds
Episode Artwork

In conversation with... Ignace Vergote and Maria Kyrgiou

Ignace Vergote (Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium) and Maria Kyrgiou (Imperial College London, London, UK) discuss their Series papers on gynaecological cancers.
25/07/202210 minutes 30 seconds
Episode Artwork

In conversation with... David J Pinato

David J Pinato (Imperial College London, London, UK) discusses the OnCovid registry study on the outcomes of the SARS-CoV-2 omicron variant outbreak among patients with cancer in Europe.
30/06/20225 minutes 19 seconds
Episode Artwork

In conversation with... Wilfred Ngwa, Beatrice Wiafe-Addai, and David Kerr

Wilfred Ngwa (Harvard Medical School, Boston, MA, USA; Johns Hopkins University, Baltimore, MD, USA; ICT University, Yaounde, Cameroon), Beatrice Wiafe-Addai (Peace and Love Hospital, Kumasi, Ghana), and David Kerr (University of Oxford, Oxford, UK) discuss the Lancet Oncology Commission on cancer in sub-Saharan Africa.
09/05/202230 minutes 55 seconds
Episode Artwork

In conversation with... Georgios Lyratzopoulos

Georgios Lyratzopoulos (Institute of Epidemiology & Health Care at University College London, London, UK) discusses his population-based study on risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission.
28/04/202213 minutes 44 seconds
Episode Artwork

In conversation with... Lisa Iezzoni and Jordan Marchak

Lisa Iezzoni (Massachusetts General Hospital, Boston, MA, USA) discusses her Series paper on disabilities and cancer and Jordan Marchak (Children’s Healthcare of Atlanta, Atlanta, GA, USA) discusses her Review on surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors.
29/03/202212 minutes 53 seconds
Episode Artwork

In conversation with... Rosie Bradley

Rosie Bradley (Oxford Population Health, University of Oxford, Oxford, UK) discusses her Article on aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression.
01/03/20224 minutes 33 seconds
Episode Artwork

In conversation with... Yi-Long Wu and Caicun Zhou

Prof Yi-Long Wu (Guangdong Lung Cancer Institute, Guangzhou, China) and Prof Caicun Zhou (Shanghai Pulmonary Hospital, Shanghai, China) discuss the GEMSTONE 301 and GEMSTONE 302 trials on sugemalimab versus placebo in non-small-cell lung cancer.
01/02/20229 minutes 56 seconds
Episode Artwork

In conversation with... Rebecca Fitzgerald

Rebecca Fitzgerald (University of Cambridge, Cambridge, UK) discusses her Article on the use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance.
01/02/20227 minutes 25 seconds
Episode Artwork

In conversation with... Elysia Alvarez

Elysia Alvarez (UC Davis Comprehensive Cancer Center, Sacramento, USA) discusses her Article on the analysis of the global burden of adolescent and young adult cancer in 2019.
31/12/20214 minutes 5 seconds
Episode Artwork

In conversation with... Aju Mathew

Aju Mathew (Malankara Orthodox Syrian Church Medical College and Hospital, Kerala, India) discusses his Review on financial toxicity in cancer care in India.
30/11/20216 minutes 8 seconds
Episode Artwork

In conversation with... David Pinato

David Pinato (Imperial College London, Hammersmith Hospital, London, UK) discusses his Article on prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection.
04/11/20218 minutes 33 seconds
Episode Artwork

In conversation with... James Glasbey

James Glasbey (UK NIHR Global Health Research Unit on Global Surgery, University of Birmingham, Birmingham, UK) discusses his Article on the effect of COVID-19 pandemic lockdowns on planned cancer surgery.
02/11/20217 minutes 12 seconds
Episode Artwork

In conversation with... Manju Sengar and Christopher Booth

Manju Sengar (Tata Memorial Centre, India) and Christopher Booth (Queen’s University Cancer Research Institute, Canada) discuss their Article on the comparison between cancer drugs deemed essential by oncologists and those included in the WHO Essential Medicines List.
27/09/202111 minutes 55 seconds
Episode Artwork

In conversation with... Rafael Cardoso and Hermann Brenner

Rafael Cardoso and Hermann Brenner (German Cancer Research Center, Heidelberg, Germany) discuss their recent paper on colorectal cancer incidence, mortality, and stage distribution in Europe.
28/06/20216 minutes 41 seconds
Episode Artwork

In Conversation with… Roberto Orecchia

Roberto Orecchia (European Institute of Oncology IRCCS) discusses the ELIOT trial on intraoperative irradiation for early breast cancer.
29/04/20216 minutes 44 seconds
Episode Artwork

In Conversation with… Hedvig Hricak, Andrew Scott, Rifat Atun, and May Abdel-Wahab

Hedvig Hricak (Memorial Sloan Kettering Cancer Center), Andrew Scott (Olivia Newton-John Cancer Research Institute), Rifat Atun (Harvard TH Chan School of Public Health), and May Abdel-Wahab (International Atomic Energy Agency) discuss The Lancet Oncology’s Commission on Medical Imaging and Nuclear Medicine.
31/03/202128 minutes 10 seconds
Episode Artwork

In conversation with... Harriet Rumgay

Harriet Rumgay (International Agency for Research on Cancer, France) discusses the recent global burden of cancer in 2020 attributable to alcohol consumption study
6 minutes 45 seconds
Episode Artwork

In conversation with... Susannah Stanway, Richard Cowan, Danielle Rodin, and Miriam Mutebi

Series authors discuss the Global Cancer Control Networks Series on how high-income countries, particularly the UK and Canada, can help with cancer control in low-income and middle-income countries.
31/08/202128 minutes 2 seconds
Episode Artwork

In conversation with... Takayuki Yoshino

Takayuki Yoshino (National Cancer Center Hospital East, Kashiwa, Japan) discusses the DESTINY-CRC01 trial on trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer.
02/06/20215 minutes 49 seconds
Episode Artwork

In Conversation With... Ariana Znaor

Ariana Znaor, International Agency for Research on Cancer, discusses her Article on breast and cervical cancers stage distributions in ten newly independent states of the former Soviet Union.
02/03/20210
Episode Artwork

In Conversation With... Sathira Perera

Sathira Perera (University of New South Wales, Australia) discusses his (and colleagues) Articles on the global use of cancer surgery.
21/01/20217 minutes 47 seconds
Episode Artwork

In Conversation With... Geke Hospers

Geke Hospers (University Medical Center Groningen, The Netherlands) discusses the RAPIDO trial Article published in The Lancet Oncology.
04/01/20216 minutes 39 seconds
Episode Artwork

The crucial role of oncology nurses in cancer care

Annie Young (University of Warwick, UK) and Julia Challinor (University of California San Francisco, USA) present their two-paper Series on Oncology Nursing.
17/11/202026 minutes 51 seconds
Episode Artwork

The effect of climate change on cancer control

Robert Hiatt (University of California San Francisco, USA) discusses his and Naomi Beyeler’s (same University) Review on climate change and cancer.
02/11/20200
Episode Artwork

Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer

Paul Sargos (Institut Bergonié, France) discusses the GETUG-AFU 17 trial and Andrew Kneebone (Royal North Shore Hospital and University of Sidney, Australia) the RAVES trial.
29/09/202016 minutes 26 seconds
Episode Artwork

Peptide receptor radionuclide therapy for neuroendocrine tumours

Lisa Bodei (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses the Review in The Lancet Oncology on molecular profiling of neuroendocrine tumours to predict response to peptide receptor radionuclide therapy.
05/09/202019 minutes 32 seconds
Episode Artwork

Larotrectinib in patients with TRK fusion-positive solid tumours

Alexander Drilon (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses a pooled analysis in The Lancet Oncology on the role of larotrectinib in patients with TRK fusion-positive solid tumours.
07/04/202013 minutes 25 seconds
Episode Artwork

The future of radiotheranostics

Ken Herrman (University Hospital Essen, Essen, Germany) discusses a Review in The Lancet Oncology on the role of injectable radiopharmaceuticals with anti-tumour effects.
11/03/20207 minutes 50 seconds
Episode Artwork

International standards for the analysis of patient-reported outcomes in cancer trials

Corneel Coens and Madeline Pe discuss recommendations from the SISAQOL Consortium for the analysis of patient-reported outcomes, published in a Policy Review in The Lancet Oncology.
03/03/202011 minutes 38 seconds
Episode Artwork

Presenting symptoms of cancer and stage at diagnosis

Monica Koo (University College London, London, UK) discusses an Article in The Lancet Oncology on presenting symptoms of cancer and stage at diagnosis in patients in England.
09/01/20206 minutes 59 seconds
Episode Artwork

Global public and philanthropic investment in childhood cancer research

Rifat Atun (Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA) discusses a Review in The Lancet Oncology on global patterns in public and philanthropic funding for childhood cancer research with Senior Editor Márcia Costa.
04/12/201914 minutes 12 seconds
Episode Artwork

Cervical cancer in India

Partha Basu (International Agency for Research on Cancer, Lyon, France) discusses a Policy Review in The Lancet Oncology on cervical cancer prevention efforts in India.
30/10/20198 minutes 48 seconds
Episode Artwork

Oropharyngeal squamous cell carcinoma

David Palma and Anthony Nichols discuss the findings from their ORATOR trial on radiotherapy or robotic surgery for oropharyngeal squamous cell carcinoma.
03/10/201918 minutes 15 seconds
Episode Artwork

Cancer in small island nations

New Zealand’s new interim Cancer Control Agency director, Diana Sarfati, discusses a series of five papers exploring cancer control in small island nations.
03/09/20197 minutes 45 seconds
Episode Artwork

Advances in radioimmunotherapy

Eric Deutsch (Gustave Roussy Comprehensive Cancer Center, Villejuif, France) presents The Lancet Oncology’s latest series on advances in radioimmunotherapy for cancer.
29/08/201913 minutes 50 seconds
Episode Artwork

International Neoadjuvant Melanoma Consortium

Georgina Long (The University of Sydney, Sydney, NSW, Australia) discusses three papers from The Lancet Oncology on neoadjuvant approaches for melanoma treatment.
02/07/201914 minutes
Episode Artwork

IMWG consensus on imaging in plasma cell disorders

Jens Hillengass discusses the new International Myeloma Working Group consensus guidelines on optimal use of imaging methods for monoclonal plasma cell disorders.
29/05/20197 minutes 4 seconds
Episode Artwork

Digital oncology

Kee Yuan Ngiam (National University Hospital Singapore, Singapore) discusses a duo of papers exploring big data and machine-learning algorithms for healthcare delivery and pathology in oncology.
16/05/20199 minutes 46 seconds
Episode Artwork

Choosing Wisely India

CS Pramesh discusses ten low-value or harmful practises that should be avoided in cancer care in India.
02/04/20190
Episode Artwork

Paediatric vertebral radiotherapy

Bianca Hoeben discusses the latest guidelines from the SIOPE radiotherapy working group on vertebral radiotherapy dose in paediatric patients.
05/03/201914 minutes 19 seconds
Episode Artwork

Malignant plural mesothelioma

Anna Bibby joins The Lancet Oncology to discuss recent developments in the treament of malignant plural mesothelioma.
02/02/201920 minutes 20 seconds
Episode Artwork

CAR T-cell therapy

Frederick Locke joins The Lancet Oncology to discuss long-term results from the ZUMA-1 trial on the safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma.
03/01/201912 minutes 44 seconds
Episode Artwork

Cervical cancer screening in older women

Talía Malagón discusses her modelling study which assesses the age at which to stop cervical cancer screening in older women and the remaining lifetime risk of cervical cancer.
29/11/201812 minutes
Episode Artwork

Palliative care in oncology

Stein Kaasa and Jon Loge discuss their new Commission on palliative care.
19/10/201810 minutes 25 seconds
Episode Artwork

Global review of cancer control

Andre Ilbawi talks about his global analysis of available national cancer control plans with The Lancet Oncology.
27/09/201810 minutes 34 seconds
Episode Artwork

Are patient reported outcomes consistent?

A review in The Lancet Oncology asks whether patient reported outcomes in RCTs are consistent across their analysis, reporting, and interpretation. Author Madeline Pe discusses the findings.
31/08/20188 minutes 4 seconds
Episode Artwork

Changing incidence of adolescent cancer

Eva Steliarova-Foucher joins The Lancet Oncology to discuss the Europe-wide Automated Childhood Cancer Information System, and the increase in cancer incidence rates among children and adolescents.
31/08/20188 minutes 53 seconds
Episode Artwork

Diffuse intrinsic pontine glioma

Mark Souweidane joins The Lancet Oncology to discuss his dose-escalation study, assessing a convection-enhanced delivery for diffuse intrinsic pontine glioma.
14/08/201822 minutes 8 seconds
Episode Artwork

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer

Bo Jan Noordman joins The Lancet Oncology to discuss the findings from his study of residual disease detection in oesophageal cancer.
30/06/20189 minutes 49 seconds
Episode Artwork

Gender and cancer immunotherapy efficacy

Fabio Conforti talks to The Lancet Oncology about a meta-analysis showing that a patient's sex can affect the efficacy of cancer immunotherapy.
01/06/20189 minutes 37 seconds
Episode Artwork

PROs in regulatory decision making

Paul Kluetz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision making.
25/04/201811 minutes 33 seconds
Episode Artwork

Vulvar field resection

Michael Hoeckel joins The Lancet Oncology to discuss his latest trial on the surgical treatment of vulvar carcinoma based on the theory of ontogenetic cancer fields.
29/03/201813 minutes 54 seconds
Episode Artwork

Chromatin organisation and cancer prognosis

Håvard Emil Danielsen joins The Lancet Oncology to discuss his latest paper on machine learning algorithms to analyse chromatin organisation as a prognostic marker for cancer.
01/03/20187 minutes 24 seconds
Episode Artwork

Trial design for brain metastases: The Lancet Oncology: Jan 2018

Ross Camidge discusses RANO's papers on clinical trial design for patients with brain metastases.
30/12/201711 minutes 11 seconds
Episode Artwork

Lung cancer screening: The Lancet Oncology: November 27, 2017

John Field discusses a European position statement on lung cancer screening using low-dose CT.
28/11/201710 minutes 29 seconds
Episode Artwork

Future cancer research priorities in the USA: The Lancet Oncology Commission: October 31, 2017

Commission co-chairs Chi Van Dang and Elizabeth M. Jaffee discuss a new Lancet Oncology Commission on cancer treatment and care in the USA.
01/11/201710 minutes 45 seconds
Episode Artwork

Cancer in Peru: The Lancet Oncology

Ben Anderson talks about cancer care and cancer trends in Peru.
28/09/201719 minutes 9 seconds
Episode Artwork

Selective internal radiotherapy for colorectal cancer: The Lancet Oncology: September 2017

Ricky Sharma discusses results from three prospective trials on the use of selective internal radiotherapy for liver metastases from colorectal cancer.
02/09/20174 minutes 16 seconds
Episode Artwork

Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017

Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses.
26/07/20178 minutes 1 second
Episode Artwork

Prior radiotherapy and pembrolizumab: The Lancet Oncology: June 28, 2017

Percy Lee discusses the impact of prior radiotherapy on the efficacy of pembrolizumab when used to treat non-small cell lung cancer.
29/06/20177 minutes 34 seconds
Episode Artwork

EANO and palliative care: The Lancet Oncology: June 2, 2017

Martin Taphoorn outlines the importance of palliative care for patients with gliomas.
03/06/20178 minutes 57 seconds
Episode Artwork

Head and neck cancer Series: The Lancet Oncology: April 26, 2017

Sandro Porceddu discusses the new Lancet Oncology Series on head and neck cancer.  
26/04/201717 minutes 4 seconds
Episode Artwork

<sup>18</sup>F-FDG PET/CT for multiple myeloma: The Lancet Oncology: April, 2017

Michele Cavo discusses the International Myeloma Working Group’s recommendations on the use of 18F-FDG PET/CT for patients with multiple myeloma and other plasma cell dyscrasias.
30/03/20175 minutes 57 seconds
Episode Artwork

Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017

Lesley Seymour discusses the iRECIST guidelines for assessing tumour responses in immunotherapy trials.
02/03/201718 minutes 17 seconds
Episode Artwork

Genomic modelling for radiation dosage: The Lancet Oncology: Feb 1 2017

Javier Torres-Roca and Louis Harrison join us to discuss their work on genome modelling and its uses in calculating the appropriate radiation dosage.
02/02/201715 minutes 46 seconds
Episode Artwork

Cancer survivorship in the USA: The Lancet Oncology: 30 December

Ann Partridge talks about cancer survival in the USA.
30/12/201611 minutes 22 seconds
Episode Artwork

Non-small cell lung cancer: The Lancet Oncology and The Lancet Respiratory Medicine: November 4, 2016

Rafael Rossell discusses RET inhibitors and non-small cell lung cancer.
05/11/201613 minutes 15 seconds
Episode Artwork

Quality of life and low-grade glioma: The Lancet Oncology: 31 October, 2016

Brigitta Baumert discusses her article on quality of life in patients with high-risk, low-grade glioma.
31/10/201611 minutes 23 seconds
Episode Artwork

Renal surveillance: The Lancet Oncology: August 30, 2016

Brian Rini discusses active surveillance for patients with metastatic renal cell carcinoma.
01/09/20169 minutes 54 seconds
Episode Artwork

Multiple myeloma: The Lancet Oncology: July 26, 2016

Shaji Kumar discusses updated consensus criteria from the International Myeloma Working Group for response and minimal residual disease assessment in multiple myeloma.
27/07/201610 minutes 45 seconds
Episode Artwork

HPV vaccination in Japan: The Lancet Oncology: June 28, 2016

Catherine Sauvaget and&nbsp;Ryo Konno discuss Japan’s low uptake of screening programmes for breast and cervical cancer.
30/06/201615 minutes 42 seconds
Episode Artwork

Antibody-drug conjugates for cancer therapy: The Lancet Oncology: June 01, 2016

Anish Thomas discusses use of antibody-drug conjugates for cancer therapy.
02/06/20169 minutes 18 seconds
Episode Artwork

Ethical issues in paediatric oncology trials: The Lancet Oncology: April 26, 2016

Jean-Claude Dupont and Fran&ccedil;ois Doz discuss ethical issues in paediatric oncology clinical trials.
27/04/201615 minutes 11 seconds
Episode Artwork

Medulloblastoma: The Lancet Oncology: March 11, 2016

Michael Taylor discusses treatment approaches to the rare brain tumour that generally affects children, medulloblastoma.
12/03/20169 minutes 57 seconds
Episode Artwork

NAB-paclitaxel and breast cancer: The Lancet Oncology: February 8, 2016

Sibylle Loibl discusses the findings and clinical implications of the GeparSepto trial.
11/02/20168 minutes 45 seconds
Episode Artwork

Rare cancers: The Lancet Oncology | February 2, 2016

Dr. Richard Carvajal discusses aspects of treatment and research for rare cancers.
03/02/20169 minutes 27 seconds
Episode Artwork

Mantle-cell lymphoma: The Lancet Oncology: January 2016

Discussion of two new treatment approaches to indolent lymphoma and mantle-cell lymphoma, haematological diseases with generally poor response to chemotherapy.
24/12/201516 minutes 10 seconds
Episode Artwork

Neuro-oncology: The Lancet Oncology, November 2015

Hideho Okada discusses immunotherapy response assessment criteria in neuro-oncology.&nbsp;
02/11/20155 minutes 16 seconds
Episode Artwork

Metastatic breast cancer: The Lancet Oncology: Sept 10, 2015

Rajendra Badwe discusses treatment options for metastatic breast cancer.
10/09/20158 minutes 43 seconds
Episode Artwork

Breast cancer: The Lancet Oncology: Aug 6, 2015

Harry Bear discusses the use of adjuvant and neoadjuvant bevacizumab in the treatment of early breast cancer.
11/08/201510 minutes 55 seconds
Episode Artwork

Watchful waiting for patients with rectal cancer: The Lancet Oncology: July 6, 2015

Ane Appelt discusses adopting a watchful waiting approach for patients with rectal cancer who achieved a clinical complete response after chemoradiotherapy.
07/07/201516 minutes 37 seconds
Episode Artwork

HPV vaccine dosing schedules: The Lancet Oncology: June 10, 2015

Amy Kreimer discusses HPV vaccine dosing schedules and cervical cancer prevention.
10/06/20157 minutes 21 seconds
Episode Artwork

RANO Group: The Lancet Oncology: May 28, 2015

Nancy Lin discusses RANO Group’s new response assessment criteria checklist.
28/05/201511 minutes 47 seconds
Episode Artwork

HPV and cancer: The Lancet Oncology: April 30, 2015

Rolando Herrero summarises three papers that constitute the HPV and cancer Series.
30/04/201517 minutes 39 seconds
Episode Artwork

Advances in cancer drug development: The Lancet Oncology: March 18, 2015

Jeffery Weber discuses advances in cancer drug development.
18/03/201511 minutes 4 seconds
Episode Artwork

The Lancet Oncology: March 02, 2015

Dr Saro Armenian discusses long term health concerns for survivors of childhood cancers.
02/03/201513 minutes 30 seconds
Episode Artwork

The Lancet Oncology: January 16, 2015

Jeff Bradley discusses standard verses high-dose radiation in conjunction with chemotherapy for patients with phase III non-small-cell lung cancer.
18/01/20156 minutes 55 seconds
Episode Artwork

The Lancet Oncology: December 16, 2014

Dennis Slamon discusses advances in breast cancer treatment based on data from the PALOMA trial.
17/12/20145 minutes 25 seconds
Episode Artwork

The Lancet Oncology: November 24, 2014

Charles Bennett discusses the development and regulatory landscape of biosimilar oncology drugs.
24/11/201415 minutes 27 seconds
Episode Artwork

The Lancet Oncology: October 27, 2014

S Vincent Rajkumar of the Mayo Clinic discusses the updated disease definition of multiple myeloma.
27/10/20147 minutes 26 seconds
Episode Artwork

The Lancet Oncology: September 17, 2014

Daniel M Green discusses the effect of treatment for childhood cancers on male fertility.
17/09/20146 minutes 2 seconds
Episode Artwork

The Lancet Oncology: August 28, 2014

Naomi Lee discusses new research about depression and cancer with Michael Sharpe and Jane Walker.
28/08/20149 minutes 41 seconds
Episode Artwork

The Lancet Oncology: July 07, 2014

Robert Hills discusses a meta-analysis of gemtuzumab ozogamicin for the treatment of adult myeloid leukaemia.
07/07/201419 minutes 16 seconds
Episode Artwork

The Lancet Oncology: June 30, 2014

Jeremy Whelan from the National Cancer Research Institute discusses the underrepresentation of teenagers and young adults in clinical cancer trials.
30/06/201413 minutes 40 seconds
Episode Artwork

The Lancet Oncology: May 27, 2014

Paul Spiegel discusses cancer in refugees in Jordan and Syria and how the UNHCR have addressed the provision of expensive cancer treatment.
27/05/20146 minutes 56 seconds
Episode Artwork

The Lancet Oncology: May 05, 2014

Laura Essermann discusses cancer over-diagnosis and over-treatment.
05/05/201413 minutes 33 seconds
Episode Artwork

The Lancet Oncology: May 02, 2014

Ian Krop discusses a phase III trial to assess efficacy of trastuzumab emtansine for women with recurrent HER2-positive breast cancer.
02/05/20149 minutes 25 seconds
Episode Artwork

The Lancet Oncology: March 19, 2014

Michael H&#246;ckel joins Natalie Harrison to discuss how surgery based on ontogenetic staging is sufficient to control cervical cancer without additional radiotherapy.
19/03/201411 minutes 13 seconds
Episode Artwork

The Lancet Oncology: February 07, 2014

Christopher Klenk and Heike E Daldrup-Link join Natalie Harrison to discuss ionising radiation-free techniques in cancer detection.
07/02/201411 minutes 39 seconds
Episode Artwork

The Lancet Oncology: January 14, 2014

Jonathan Banks discusses the aims and implications of a study into public preferences for cancer testing.
14/01/20148 minutes 13 seconds
Episode Artwork

The Lancet Oncology: December 05, 2013

Roberta de Angelis discusses the results and implications of the EUROCARE 5 study
05/12/201313 minutes 48 seconds
Episode Artwork

The Lancet Oncology: November 11, 2013

Jayant Vaidya and Umberto Veronesi discuss the TARGIT and ELIOT trials of intraoperative radiotherapy for early breast cancer
11/11/201315 minutes 2 seconds
Episode Artwork

The Lancet Oncology: October 14, 2013

Ramon Luengo-Fernandez discusses the cost of cancer care in the European Union.
14/10/20138 minutes 34 seconds
Episode Artwork

The Lancet Oncology: September 02, 2013

Jesus San Miguel discusses a phase 3 trial comparing pomalidomide plus low-dose dexamethasone with high-dose dexamethasone in patients with multiple myeloma.
02/09/20137 minutes 22 seconds
Episode Artwork

The Lancet Oncology: July 10, 2013

Ole Raaschou-Nielsen discusses the association between long-term exposure to ambient air pollution and lung cancer risk.
10/07/20134 minutes 38 seconds
Episode Artwork

The Lancet Oncology: June 07, 2013

Perry Pickhardt discusses the value of CT colonography to determine whether small colorectal polyps will progress or not.
07/06/201310 minutes 40 seconds
Episode Artwork

The Lancet Oncology: May 15, 2013

Thorsten Kuehn discusses the SENTINA study, concerning centinel lymph node biopsy before and after neoadjuvant chemotherapy in breast cancer.
15/05/201311 minutes 3 seconds
Episode Artwork

The Lancet Oncology: April 26, 2013

Paul Goss presents an overview of The Lancet Oncology Commission on cancer prevention in Latin America.
26/04/20136 minutes 53 seconds
Episode Artwork

The Lancet Oncology: April 16, 2013

Yael Mosse discusses a phase I study about the potential of targeted molecular therapy for childhood cancers.
16/04/20138 minutes 20 seconds
Episode Artwork

The Lancet Oncology: April 03, 2013

Sulma Mohammed discusses a pilot study of breast cancer screening in rural Sudan.
03/04/201311 minutes 13 seconds
Episode Artwork

The Lancet Oncology: February 20, 2013

Kathy Pritchard-Jones discusses a Series about paediatric oncology.
20/02/201312 minutes 1 second
Episode Artwork

The Lancet Oncology: January 25, 2013

John Farley discusses a trial of the MEK inhibitor selumetinib for the treatement of low-grade serous carcinoma of the ovary and peritoneum.
26/01/20136 minutes 47 seconds
Episode Artwork

The Lancet Oncology: December 04, 2012

Nicole Krekel discusses a trial which assesses ultrasound-guided breast conserving surgery in the management of breast cancer.
04/12/20128 minutes 22 seconds
Episode Artwork

The Lancet Oncology: November 14, 2012

Anticancer drugs: doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours.
14/11/20128 minutes 16 seconds
Episode Artwork

The Lancet Oncology: October 30, 2012

Asian Oncology Summit: Consensus guidelines on palliative care, kidney cancer, and colorectal cancer.
30/10/201212 minutes 57 seconds
Episode Artwork

The Lancet Oncology: August 23, 2012

Discussion of a UK/French study into adult diabetes risk after radiation for childhood cancer.
23/08/20124 minutes 12 seconds
Episode Artwork

The Lancet Oncology: August 06, 2012

Gustavo Ismael discusses subcutaneous versus intravenous administration of trastuzumab in patients with breast cancer.
06/08/20124 minutes 12 seconds
Episode Artwork

The Lancet Oncology: July 13, 2012

Discussion of the oral MEK inhibitor trametinib in cancer treatment. .
13/07/20129 minutes 31 seconds
Episode Artwork

The Lancet Oncology: June 06, 2012

Circulating tumour cells as a possible prognostic marker for non-metastatic breast cancer.
06/06/20129 minutes 33 seconds
Episode Artwork

The Lancet Oncology: May 01, 2012

Matthias Kloor discusses the prevalence of mismatch repair-deficient crypt foci in Lynch syndrome.
01/05/201215 minutes 35 seconds
Episode Artwork

The Lancet Oncology: March 23, 2012

Andrew Grulich discusses his paper looking at HPV infection and anal cancer.
23/03/20128 minutes 45 seconds
Episode Artwork

The Lancet Oncology: February 22, 2012

The association between endometriosis and ovarian cancer.
22/02/20127 minutes 6 seconds
Episode Artwork

The Lancet Oncology: February 10, 2012

The effect of chemotherapy in pregnancy on health outcomes in young children.
10/02/201210 minutes 56 seconds
Episode Artwork

The Lancet Oncology: January 30, 2012

Discussion of updated guidelines for the appropriate use of opioids in the management of cancer pain.
30/01/20129 minutes 23 seconds
Episode Artwork

The Lancet Oncology: November 25, 2011

HLA matching of transplanted umbilical-cord blood for treating leukaemia and myelodysplastic syndrome.
25/11/20116 minutes 41 seconds
Episode Artwork

The Lancet Oncology: November 14, 2011

Comparison of CT colonography with conventional colonoscopy for colorectal cancer screening.
14/11/20116 minutes 41 seconds
Episode Artwork

The Lancet Oncology: October 28, 2011

Discussion of a promising antiangiogenic approach for the treatment of ovarian cancer, and other highlights from the November issue.
28/10/201111 minutes 54 seconds
Episode Artwork

The Lancet Oncology: September 30, 2011

October highlights, including discussion of the trial about the tyrosine kinase ALK and non-small-cell lung cancer.
30/09/201112 minutes 45 seconds
Episode Artwork

The Lancet Oncology: September 26, 2011

David Collingridge launches The Lancet Oncology Commission on delivering affordable cancer care in high-income countries.
26/09/201151 minutes 39 seconds
Episode Artwork

The Lancet Oncology: August 26, 2011

September issue highlights, including discussion of HPV testing and cytology.
26/08/20119 minutes 58 seconds
Episode Artwork

The Lancet Oncology: July 29, 2011

The role of dignity therapy in end-of-life cancer care.
29/07/201110 minutes 57 seconds
Episode Artwork

The Lancet Oncology: June 24, 2011

Emma Grainger with July highlights, and an interview about a trial assessing the value of zoledronic acid in the treatment of pre-menopausal early breast cancer.
24/06/201111 minutes 37 seconds
Episode Artwork

The Lancet Oncology: May 27, 2011

June issue highlights, including faecal blood tests to assess future colorectal cancer risk, and of the &#39;dangerous liaison&#39; between cancer and tuberculosis.
27/05/20117 minutes 21 seconds
Episode Artwork

The Lancet Oncology: April 29, 2011

May highlights, including discussion of a phase II study about the treatment of B-cell lymphoma in very old patients.
29/04/20118 minutes 38 seconds
Episode Artwork

The Lancet Oncology: April 01, 2011

April issue highlights, including the latest developments of the breast Health Global Initiative(BHGI), including an interview with BHGI Director Benjamin Anderson.
01/04/201118 minutes 23 seconds
Episode Artwork

The Lancet Oncology: March 01, 2011

March issue highlights, including new data from the HERA trial about long-term efficacy of herceptin for early breast cancer.
01/03/20119 minutes 37 seconds
Episode Artwork

The Lancet Oncology: January 31, 2011

Rob Brierley with February highlights, including the prevalence of depression among cancer patients.
31/01/20115 minutes 13 seconds
Episode Artwork

The Lancet Oncology: December 30, 2010

January highlights, including automated verses manual cytology for detection of cervical cancers.
30/12/20109 minutes 40 seconds
Episode Artwork

The Lancet Oncology: November 29, 2010

December issue highlights, including mammography screening for younger women with familial breast cancer.
29/11/20104 minutes 2 seconds
Episode Artwork

The Lancet Oncology: November 01, 2010

November issue highlights, including an large-scale HPV genotype analysis with implications for cervical-cancer vaccine development, and the potential for discontinuation of imatinib treatment for people with chronic myeloid leukaemia.
01/11/20104 minutes 2 seconds
Episode Artwork

The Lancet Oncology: October 04, 2010

Includes author interview about a trial comparing sentinal-lymph-node biopsy with axillary-lymph-node dissection in breast cancer treatment.
04/10/201014 minutes 21 seconds
Episode Artwork

The Lancet Oncology: September 01, 2010

September issue highlights, including discussion of a possible association between hepatitis B infection and non-Hodgkin lymphoma in a Korean population.
01/09/20105 minutes 14 seconds
Episode Artwork

The Lancet Oncology: August 02, 2010

August issue highlights, including bevacizumab for NSCLC, and cancer issues among people with mental illness.
02/08/20107 minutes 52 seconds
Episode Artwork

The Lancet Oncology: July 05, 2010

Roy Herbst discusses the Zodiac trial, a phase 3 study assessing the efficacy of vandetanib for treating advanced non-small-cell lung cancer.
05/07/201010 minutes 7 seconds
Episode Artwork

The Lancet Oncology: June 01, 2010

Emma Grainger discusses erlotinib as maintenance treatment for lung cancer, and IGF1 and risk of breast cancer.
01/06/201011 minutes 28 seconds
Episode Artwork

The Lancet Oncology: April 29, 2010

The role of zoledronic acid with chemotherapy for early breast cancer and other issue highlights are discussed.
29/04/201012 minutes 12 seconds
Episode Artwork

The Lancet Oncology: March 29, 2010

April issue highlights, including a genome-wide association study of lung cancer for never smokers.
29/03/20107 minutes 2 seconds
Episode Artwork

The Lancet Oncology: March 01, 2010

March issue highlights, including hypofractionated radiotherapy for early breast cancer.
01/03/20104 minutes 55 seconds
Episode Artwork

The Lancet Oncology: February 01, 2010

Discussion of phase I novel targeted therapy for sarcoma.
01/02/20107 minutes 27 seconds
Episode Artwork

The Lancet Oncology: January 06, 2010

Emma Grainger with issue highlights and Kathy Albain discussing chemotherapy and tamoxifen for post-menopausal women with breast cancer.
06/01/201016 minutes 18 seconds
Episode Artwork

The Lancet Oncology: December 01, 2009

Audrey Ceschia discusses issue highlights, including impact of HIV infection on cancer risk.
01/12/20098 minutes 23 seconds
Episode Artwork

The Lancet Oncology: October 29, 2009

Discussion of new oncology management guidelines derived from didactic workshops at the Asia Oncology Summit 2009.
29/10/200925 minutes 27 seconds
Episode Artwork

The Lancet Oncology: September 28, 2009

Rob Brierley discusses an antithrombolic agent for patients receiving chemotherapy for solid tumours.
28/09/20095 minutes 27 seconds
Episode Artwork

The Lancet Oncology: August 27, 2009

Discussion of prostate cancer treatment, the PASSION-P trial, and a new Quackery column.
27/08/200912 minutes 44 seconds
Episode Artwork

The Lancet Oncology: July 29, 2009

Rob Brierley discusses sunitinib for kidney cancer, and how bureaucracy is stifling UK clinical research.
29/07/20095 minutes 46 seconds
Episode Artwork

The Lancet Oncology: July 01, 2009

Emma Grainger discusses bariatric surgery, weight loss, and cancer risk for obese people.
01/07/200911 minutes 34 seconds
Episode Artwork

The Lancet Oncology: May 28, 2009

Audrey Ceschia discusses issue highlights, including treatment for nausea and vomiting from chemotherapy.
28/05/200910 minutes 42 seconds
Episode Artwork

The Lancet Oncology: April 29, 2009

David Collingridge discusses research articles on prophylactic cranial irradiation for small-cell lung cancer, and the addition of temozolomide to radiotherapy for treating glioblastoma.
29/04/200910 minutes 1 second
Episode Artwork

The Lancet Oncology: March 30, 2009

Rob Brierley discusses research articles on cancer survival in England, and the potential for ovarian cancer screening.
30/03/20095 minutes 29 seconds
Episode Artwork

The Lancet Oncology: March 05, 2009

Emma Grainger discusses articles on myelodysplastic syndromes, circulating tumour cells and prostate cancer, and palliative stents for oesophageal cancer.
05/03/200913 minutes 27 seconds
Episode Artwork

The Lancet Oncology: January 30, 2009

Rob Brierley discusses two research articles investigating genetic subtypes of childhood acute lymphoblastic leukaemia.
30/01/20095 minutes 53 seconds
Episode Artwork

The Lancet Oncology: December 23, 2008

Emma Grainger discusses liver transplantation criteria, sorafenib for liver cancer in the Asia-Pacific, and NICE guidance on erlotinib for non-small-cell lung cancer.
23/12/200812 minutes 42 seconds
Episode Artwork

The Lancet Oncology: November 26, 2008

David Collingridge discusses a research article comparing microsurgery with total excision for basal-cell carcinoma of the face, and other content highlights.
26/11/20089 minutes 38 seconds
Episode Artwork

The Lancet Oncology: October 28, 2008

Rob Brierley introduces the latest issue, including research articles about prostate cancer and a review highlighting the importance of appropriate palliative care.
28/10/20085 minutes 30 seconds
Episode Artwork

The Lancet Oncology: October 01, 2008

John Sellors and Guglielmo Ronco discuss HPV screening for precursors of cervical cancer.
01/10/200816 minutes 36 seconds
Episode Artwork

The Lancet Oncology: August 26, 2008

Sally van der Meer discusses highlights from the September journal in this issue&#39;s podcast, including a new treatment option for preventing bone mineral loss among pre-menopausal women receiving hormone therapy for early breast cancer.
26/08/20088 minutes 40 seconds
Episode Artwork

The Lancet Oncology: August 11, 2008

The Lancet Oncology podcast - a global health theme for the August issue. Editor David Collingridge discusses the highlights, including cancer survival from five continents, and a review of cancer issues in Africa.
11/08/200811 minutes 30 seconds
Episode Artwork

The Lancet Oncology: June 30, 2008

TLO Editor David Collingridge discusses some highlights from the July issue: radiofrequency ablation showing promise for the treatment of lung cancer; how a rare form of obesity could negatively affect treatment outcomes; and a discussion of a recent meeting at IARC in Lyon, France, concerning the latest evidence on smoke-free policies and the effects on public health.
30/06/20088 minutes 56 seconds
Episode Artwork

The Lancet Oncology: June 09, 2008

Emma Cannell and Sally van der Meer discuss highlights from the June issue: a prospective pilot study assessing the role of stellate-ganglion block to treat hot flushes in survivors of breast cancer; also discussed is a Personal View about cancer of unknown primary (CUP), and the Leading Edge on public confidence in Merck&#39;s HPV vaccine.
09/06/200813 minutes 30 seconds
Episode Artwork

The Lancet Oncology: April 30, 2008

Editor David Collingridge discusses highlights from the May issue: the natural history of cervical intraepithelial neoplasia; the effect of screening on prostate-cancer mortality in the USA and UK; and the launch of a series of reviews about cancer in indigenous populations, starting this month with cancer among indigenous Polynesians.
30/04/200812 minutes 50 seconds
Episode Artwork

The Lancet Oncology: March 26, 2008

Editor David Collingridge discusses highlights from the April issue including: encouraging results from the START trials suggest fewer fractions of radiotherapy could revolutionise treatment of early stage breast cancer; how a phase II study investigating yttrium-90 labelled ibritumomab could have an important future role in the treatment of follicular non-Hodgkin lymphoma, and finally the pressing need for increased recruitment of adolescents and young adults in to cancer trials.
26/03/200812 minutes 25 seconds
Episode Artwork

The Lancet Oncology: February 25, 2008

Dr David Collingridge, Editor of the Lancet Oncology, discusses highlights of the March issue in the first Lancet Oncology podcast. Two main topics are discussed: a research article highlighting how individuals in the United States who are under-insured or who have no medical insurance are at an increased risk of presenting with late-stage cancers; non-whites are at a similarly increased cancer risk. Also featured is a Dutch study showing the potential benefits of a shared-care programme between family doctors and oncology clinics for the long-term follow-up of individuals diagnosed with cancer in childhood.
25/02/200812 minutes 52 seconds
Episode Artwork

In conversation with... Wanda Cui

Dr. Wanda Cui (Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia) discusses her Review on measuring ovarian toxicity in clinical trials.
01/01/00010
Episode Artwork

In conversation with... Philipp Karschnia

Doctor Philipp Karschnia (Ludwig-Maximilians-University of Munich, Munich, Germany) discusses the Response Assessment in Neuro Oncology consortium’s recommendations on standardised tissue sampling and processing during resection of diffuse intracranial glioma.
01/01/000117 minutes 10 seconds
Episode Artwork

In conversation with... Mike Sathekge

Professor Mike Sathekge (Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa) discusses his Article entitled, ‘Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre retrospective study.’
01/01/000116 minutes 6 seconds